September 2014 FDA Recall Losartan Potassium by Micro Labs Usa, Inc S
D-0253-2015 - Failed Content Uniformity Specifications; Dry mix failed blend uniformity.

This Class II drug recall was voluntarily initiated by Micro Labs Usa, Inc S on September 22, 2014 for the product Losartan Potassium. The FDA reported the reason for recall as failed content uniformity specifications; dry mix failed blend uniformity.. The product was distributed in U.S. Including: New York and the recall is currently terminated.

Recall Number: D-0253-2015

Reason for Recall
Failed Content Uniformity Specifications; Dry mix failed blend uniformity.
Initiated
09-22-2014
Reported
11-26-2014
Quantity
144 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Micro Labs Usa, Inc S
U.S. Including: New York
LOSARTAN POTASSIUM TABLETS USP, 25 mg, 1000 Tablet Bottles, Rx Only. Manufactured by: Micro Labs Limited, Goa-403 722, INDIA. Manufactured for: Micro Labs USA, Inc., Princeton, NJ 08540. NDC 42571-110-10

Batch or Lot Expiration Information

Lot# LJAG003, Expiry: 05/2015